Fidelity Investments’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
Fidelity Investments's RXST Position: Q3 2026 in Review
Fidelity Investments reduced its RxSight (RXST) stake by 43% in Q3 2026, selling an estimated $72.6K and leaving 16,556 shares worth $81.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4109.
Fidelity Investments first reported a position in RXST in Q1 2022 and has held it in 19 quarters since. The position peaked at $75.5M in Q2 2024. 156 funds tracked by Wall St. Rank hold RXST as of Q3 2026.
- Fidelity Investments held 16,556 shares of RxSight worth $81.1K as of Q3 2026.
- Fidelity Investments sold 12,365 RxSight shares in Q3 2026, an estimated $72.6K.
- RxSight made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #4109 holding.
- Fidelity Investments first reported a position in RxSight in Q1 2022 and has held it in 19 quarters since.
- Fidelity Investments's RxSight position peaked at $75.5M in Q2 2024.
- 156 funds tracked by Wall St. Rank held RxSight as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.